Orphanet: Recherche simple
x

Rechercher un essai clinique

* (*) Champ obligatoire

58 Résultat(s)

Trier par

Essai en cours de recrutement = Essai en cours de recrutement; Essai en cours = Essai en cours; Financé par un membre IRDiRC = ; Membre d'un ERN =

Essai(s) clinique(s) national(aux)

ALLEMAGNE

Baden-Württemberg
HEIDELBERG

ALLEMAGNE

Baden-Württemberg
HEIDELBERG

Essai en coursAn open-label, phase 1/2 study of melflufen and dexamethasone for patients with al amyloidosis following at least one prior line of therapy - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

PORTUGAL

NORTE
PORTO

Essai en cours de recrutementEssai en coursTrial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis (Phase I)
Hospital de Santo António - Centro Hospitalar do Porto
Unidade Clínica de Paramiloidose

PORTUGAL

NORTE
PORTO

Essai en coursOpen-Label Safety and Efficacy Evaluation of Fx-1006A in Patients With Transthyretin Amyloidosis (Phase II/III)
Hospital de Santo António - Centro Hospitalar do Porto
Unidade Clínica de Paramiloidose

ROYAUME-UNI

Greater London
LONDON

Essai en coursA randomized open-label multicenter phase III trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for untreated patients with systemic light-chain (AL) amyloidosis - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

ROYAUME-UNI

Greater London
LONDON

ROYAUME-UNI

Greater London
LONDON

Essai(s) clinique(s) multinational(aux)

FRANCE

ILE-DE-FRANCE
PARIS

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US